Crohn's Disease and Colitis Trial, Recruiting NCT04859088 Sponsor: NHS Greater Glasgow and Clyde Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT04859088
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 16 years old or older
  • You have been diagnosed with active Crohn's disease, confirmed by a standard disease activity score (confirm with trial site)
  • You are about to start a standard course of a medication called adalimumab (also known as a TNF-alpha blocker) for the first time

Who may not be able to join:

  • You are unable or unwilling to give written consent to take part
  • You are currently pregnant or breastfeeding
  • You have a stoma (a surgically created opening on your abdomen for waste to leave the body)
  • You have short bowel syndrome (a condition where part of the small intestine is missing or not working properly)
  • You have previously been treated with any anti-TNF medication (a type of biological drug that targets inflammation)
  • You have used certain other biological or advanced oral treatments for Crohn's disease in the last 12 weeks
  • You are currently taking steroid tablets or steroid infusions at a dose higher than a certain level (confirm with trial site)
  • Your dose of certain immune-suppressing medications (such as azathioprine, mercaptopurine, or methotrexate) has been started or changed in the last 8 weeks
  • You have taken oral antibiotics in the last 4 weeks
  • Your Crohn's disease mainly involves large fistulas (abnormal tunnels in the body) or significant narrowing/scarring of the bowel
  • You have tested positive for certain blood-borne viruses such as HIV or hepatitis
  • You have untreated tuberculosis (TB), whether active or in a dormant/latent form
  • You are currently taking part in another clinical trial involving an investigational product or a specific diet
  • You have food allergies that would prevent you from taking part, for example a cow's milk allergy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 07743585420

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
NHS Greater Glasgow and Clyde
Registry
ClinicalTrials.gov
Start date
20 September 2021
Est. completion
1 September 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Crohn's Disease Activity Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov